Roivant Sciences Ltd. — SEC insider filings
SEC reporting owner CIK 1635088. 9 insider filings on record with FilingPulse; latest filed 2026-10-05.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2020-09-04 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 5 filings — 35,834,659 shares, $759,940,196 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: purchase of 16,666,666 shares @ $21.00 ($349,999,986) in Immunovant, Inc., filed 2025-12-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | Director, 10% owner | 7 | 5 legs · 35,834,659 sh · $759,940,196 | — | 3 |
| Arbutus Biopharma Corp (ABUS) | Director, 10% owner | 2 | — | — | 3 |
Insider filings — Roivant Sciences Ltd.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-05 | 4 | Arbutus Biopharma Corp (ABUS) | Disposition to issuer (D): 8,967,383 @ $5 | EDGAR |
| 2025-12-12 | 4 | Immunovant, Inc. (IMVT) | Purchase (P): 16,666,666 @ $21 | EDGAR |
| 2025-01-15 | 4 | Immunovant, Inc. (IMVT) | Purchase (P): 16,845,010 @ $20 | EDGAR |
| 2023-10-04 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 4,473,684 @ $38 · Purchase (P): 1,526,316 @ $38 | EDGAR |
| 2022-10-07 | 4 | Immunovant, Inc. (IMVT) | Purchase (P): 416,667 @ $6 | EDGAR |
| 2021-10-20 | 4 | Arbutus Biopharma Corp (ABUS) | Conversion (C): 22,833,922 · Conversion (C): 1,164,000 (derivative) | EDGAR |
| 2021-08-02 | 4 | Immunovant, Inc. (IMVT) | Other (J): 17,021,276 | EDGAR |
| 2020-09-18 | 4 | Immunovant, Inc. (IMVT) | Other (J): 8,773,969 | EDGAR |
| 2020-09-04 | 4 | Immunovant, Inc. (IMVT) | Purchase (P): 380,000 @ $33 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1635088 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs